Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June, 2024
|
| In: |
Haematologica
Year: 2024, Jahrgang: 109, Heft: 6, Pages: 1629-1630 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2024.285624 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2024.285624 Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/11605 
|
| Verfasserangaben: | Richard F. Schlenk |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1913731499 | ||
| 003 | DE-627 | ||
| 005 | 20250716220955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250107s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2024.285624 |2 doi | |
| 035 | |a (DE-627)1913731499 | ||
| 035 | |a (DE-599)KXP1913731499 | ||
| 035 | |a (OCoLC)1528015451 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 245 | 1 | 0 | |a Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia |c Richard F. Schlenk |
| 264 | 1 | |c June, 2024 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.01.2025 | ||
| 500 | |a Veröffentlicht: 2024-06-01 | ||
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 109(2024), 6 vom: Juni, Seite 1629-1630 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia |
| 773 | 1 | 8 | |g volume:109 |g year:2024 |g number:6 |g month:06 |g pages:1629-1630 |g extent:2 |a Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2024.285624 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/11605 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250107 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1913731499 |e 4645899716 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 07.01.2025","Veröffentlicht: 2024-06-01"],"person":[{"given":"Richard Friedrich","display":"Schlenk, Richard Friedrich","family":"Schlenk","role":"aut"}],"recId":"1913731499","name":{"displayForm":["Richard F. Schlenk"]},"language":["eng"],"origin":[{"dateIssuedDisp":"June, 2024","dateIssuedKey":"2024"}],"relHost":[{"origin":[{"dateIssuedKey":"2014","publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-"}],"title":[{"title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2805244-4"],"eki":["814204899"],"issn":["1592-8721"]},"recId":"814204899","titleAlt":[{"title":"journal of the European Hematology Association"}],"disp":"Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemiaHaematologica","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 27.05.2022"],"pubHistory":["99.2014 -"],"language":["eng"],"part":{"year":"2024","volume":"109","text":"109(2024), 6 vom: Juni, Seite 1629-1630","issue":"6","extent":"2","pages":"1629-1630"}}],"physDesc":[{"extent":"2 S."}],"id":{"eki":["1913731499"],"doi":["10.3324/haematol.2024.285624"]},"title":[{"title":"Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia","title_sort":"Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a SCHLENKRICGENETICSAS2024 | ||